Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
ISS09 - Industry Supported Symposium: Targeted Therapy on the Horizon for SCLC - AbbVie
- Type: Industry Supported Symposium
- Track:
- Presentations: 5
- Moderators:M. Reck
- Coordinates: 12/06/2016, 07:30 - 08:30, Lehar 3-4
-
+
ISS09.01 - Challenges in SCLC Across Decades
07:30 - 07:40 | Author(s): M. Reck
- Abstract
No abstract available for this presentation
-
+
ISS09.02 - Advancing the Study in SCLC – What is the Underlying Biology?
07:40 - 07:55 | Author(s): J. Soria
- Abstract
No abstract available for this presentation
-
+
ISS09.03 - Emerging Novel Agents – A New Day for SCLC Treatment
07:55 - 08:15 | Author(s): R. Govindan
- Abstract
No abstract available for this presentation
-
+
ISS09.04 - Panel Discussion: Looking Over the Horizon – Future Treatment of SCLC
08:15 - 08:25 | Author(s): M. Reck
- Abstract
No abstract available for this presentation
-
+
ISS09.05 - Question & Answer
08:25 - 08:30 | Author(s): M. Reck
- Abstract
No abstract available for this presentation
-
+
MA07 - ALK-ROS1 in Advanced NSCLC
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Presentations: 12
- Moderators:N. Singh
- Coordinates: 12/06/2016, 11:00 - 12:30, Lehar 1-2
-
+
MA07.05 - EUCROSS: A European Phase II Trial of Crizotinib in Advanced Adenocarcinoma of the Lung Harboring ROS1 Rearrangements - Preliminary Results
11:30 - 11:36 | Author(s): S. Michels
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA11 - Angiogenesis in Advanced Lung Cancer
- Type: Oral Session
- Track: Advanced NSCLC
- Presentations: 8
- Moderators:L.M. Montuenga
- Coordinates: 12/06/2016, 11:00 - 12:30, Stolz 2
-
+
OA11.02 - Randomized Phase 1b/3 Study of Erlotinib plus Ramucirumab in First-Line EGFR Mut + Stage IV NSCLC: Phase 1b Safety Results
12:10 - 12:20 | Author(s): K. Nakagawa
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA14 - Immunotherapy in Advanced NSCLC: Biomarkers and Costs
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Presentations: 12
- Moderators:M. Reck
- Coordinates: 12/06/2016, 16:00 - 17:30, Strauss 2
-
+
MA14.01 - Updated Dataset Assessing Tumor Mutation Burden (TMB) as a Biomarker for Response to PD-1/PD-L1 Targeted Therapies in Lung Cancer (LC)
16:00 - 16:06 | Author(s): A.B. Schrock
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA14.02 - Evaluation of PD1/PDL1 Expression on Peripheral Blood Cells Subpopulations in Patients with Non-Small Cell Lung Cancer
16:06 - 16:12 | Author(s): O. Arrieta
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA14.03 - The Impact of Genomic Landscape of EGFR Mutant NSCLC on Response to Targeted and Immune Therapy
16:12 - 16:18 | Author(s): Y.Y. Elamin
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA14.04 - Discussant for MA14.01, MA14.02, MA14.03
16:18 - 16:30 | Author(s): M. Moniuszko
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA14.05 - Implications of Implementation of a PD-L1 Biomarker-Based Strategy for Treatment of Advanced NSCLC
16:30 - 16:36 | Author(s): M. Huang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA14.06 - Nivolumab in Never Smoker Patients with Advanced Squamous NSCLC: Results from the Italian Expanded Access Programme (EAP)
16:36 - 16:42 | Author(s): G. Lo Russo
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA14.07 - Real Life Experience with Immunotherapy in the Netherlands
16:42 - 16:48 | Author(s): R.D. Schouten
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA14.08 - Discussant for MA14.05, MA14.06, MA14.07
16:48 - 17:00 | Author(s): L.E. Raez
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA14.09 - Demonstrating Life Expectancy Gains with Immuno-Oncology (IO) Therapies
17:00 - 17:06 | Author(s): J. Sullivan
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA14.10 - Relative Impact of Disease Management Costs in the Economics of Pembrolizumab in Previously Treated PD-L1 Positive Advanced NSCLC
17:06 - 17:12 | Author(s): M. Huang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA14.11 - An Estimate of the Economic Impact of Immunotherapy Relative to PD-L1 Expression in Brazil - An Update with Brazilian Costs
17:12 - 17:18 | Author(s): P. Aguiar Jr
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA14.12 - Discussant for MA14.09, MA14.10, MA14.11
17:18 - 17:30 | Author(s): G.R. Simon
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL04a - Plenary Session: Immune Checkpoint Inhibitors in Advanced NSCLC
- Type: Plenary
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 5
- Moderators:J. Soria
- Coordinates: 12/07/2016, 08:45 - 09:40, Hall D (Plenary Hall)
-
+
PL04a.01 - Health-Related Quality of Life for Pembrolizumab vs Chemotherapy in Advanced NSCLC with PD-L1 TPS ≥50%: Data from KEYNOTE-024 (Abstract under Embargo until December 7, 7:00 CET)
08:45 - 08:55 | Author(s): J.R. Brahmer
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
SC26 - Angiogenesis Inhibition: Advances & Perspectives
- Type: Science Session
- Track: Biology/Pathology
- Presentations: 5
- Moderators:T. Seto
- Coordinates: 12/07/2016, 11:00 - 12:30, Lehar 3-4
-
+
SC26.03 - Predictive Biomarkers for Angiogenesis Inhibitors: An Update
11:40 - 12:00 | Author(s): M. Reck
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA22 - Novel Trials and Biomarkers in Malignant Pleural Mesothelioma
- Type: Oral Session
- Track: Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Presentations: 8
- Moderators:H. Pass
- Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 3
-
+
OA22.02 - Nintedanib plus Pemetrexed/Cisplatin in Patients with MPM: Phase II Findings from the Placebo-Controlled LUME-Meso Trial
14:30 - 14:40 | Author(s): F. Grosso
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.02a - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 37
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.02a-026 - Crizotinib in Clinical Practice and in Clinical Trials - How Much the Results Differ?
14:30 - 14:30 | Author(s): P. Kasan
- Abstract
Loading...
-
+
P3.02c - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 103
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.02c-030 - Use of a 200-Mg Fixed Dose of Pembrolizumab for the Treatment of Advanced Non–Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): E.B. Garon
- Abstract
Loading... -
+
P3.02c-038 - First-Line Atezolizumab plus Chemotherapy in Chemotherapy-Naïve Patients with Advanced NSCLC: A Phase III Clinical Program
14:30 - 14:30 | Author(s): F. Cappuzzo
- Abstract
Loading... -
+
P3.02c-041 - IMpower133: A Phase I/III Study of 1L Atezolizumab with Carboplatin and Etoposide in Patients with Extensive-Stage SCLC
14:30 - 14:30 | Author(s): S.V. Liu
- Abstract
Loading...